KospicyKorean filings in English
Filings / DongKoo Bio & Pharma Co., Ltd.

Beneficial Ownership Report (5%) — Standard Form

DongKoo Bio & Pharma Co., Ltd. · 주식등의대량보유상황보고서(일반)

SC 13D/GKOSDAQ · 006620 Filed 2026-11-09Korean original on DART

English form view 68% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Report on large shareholdings (general)

6.1

(주)동구바이오제약

0000

Report on Large Holdings of Shares, etc.

(General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control)
To: Financial Services CommissionReporting obligation date:2026-11-06
To: Korea ExchangeReport reference date:2026-11-06
Reporting person:조 용 준
Summary
Issuer name(주)동구바이오제약Relationship to IssuerLargest Shareholder
Report TypeChange
Number of Shares Held and Holding RatioNumber of Shares HeldHolding Ratio
Previous Report10,604,67837.18
Current Report10,611,42437.20
Shares under key agreements: number and ratioNumber of shares, etc.Ratio
Previous Report7,547,13926.46
Current Report7,547,13926.46
Number of voting rights and holding ratioNumber of Voting RightsHolding Ratio
Previous Report--
Current Report--
Voting rights under key agreements: number and ratioNumber of Voting RightsRatio
Previous Report--
Current Report--
Reason for Report장내 거래에 따른 보유주식수 변동 보고
※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission.

Part 1 Report Overview

1. Issuer information

Company Name(주)동구바이오제약Company code006620
Entity typeKOSDAQ-Listed CompanyTotal Issued Voting Shares (shares)28,464,992

2. Major shareholder information

a. Reporting person

(1) Reporting person overview

Report TypeChangeJoint signatories
Reporting person typeIndividual (Domestic)NationalityRepublic of Korea
Basis for Reporter Classification (only if reported as a statutory partnership or other entity)-
Name (Entity Name)Korean조 용 준Chinese characters (English)趙容焌(Cho Yong Joon)
Address (Head Office) [Town/District Level Only]서울시 강남구 청담동Date of Birth or Business Registration No., etc.660612
Occupation (business)(주)동구바이오제약 대표이사Relationship to IssuerLargest Shareholder
Business contact and person in chargeAffiliated company(주)동구바이오제약DepartmentIPR팀
PositionDirectorPhone Number02-268**
Name박승준Fax number02-268**
Email address**[email protected]

(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)

Legal form-
Total Assets (or Total Assets Under Management)-Total Liabilities-
Total Equity-Paid-in Capital-
Representative (representative or managing partner)-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Largest Investor)-Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)-

b. Specially related parties

(1) Specially related party overview

No.NameCategorySpecific Relationship to ReporterDate of Birth or Business Registration No., etc.NationalityAddress (Location)Occupation (Business)Relationship to Issuer
1이경옥Individual (Domestic)Relatives391210Republic of Korea서울시 강남구 압구정동-De facto controlling shareholder
2김도형Individual (Domestic)Relatives730123Republic of Korea서울시 서초구 방배동(주)로프티록인베스트먼트 대표이사Shareholder
3조은숙Individual (Domestic)Relatives640620Republic of Korea서울시 강남구 압구정동-Shareholder
4조은경Individual (Domestic)Relatives690507Republic of Korea서울시 강남구 압구정동-Shareholder
5조유진Individual (Domestic)Relatives980126Republic of Korea서울시 강남구 청담동-Shareholder
6조호윤Individual (Domestic)Relatives021107Republic of Korea서울시 강남구 청담동-Shareholder
7신중현Individual (Domestic)Executive610620Republic of Korea서울시 마포구 용강동(주)동구바이오제약경영총괄대표(COO)Executive officers (registered)
8장준일Individual (Domestic)Executive730528Republic of Korea경기도 화성시 동탄구 반송동(주)동구바이오제약재무전략본부장Executive officers (registered)
* Address to town/district level only

(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)

Legal form-
Total Assets (or Total Assets Under Management)-Total Liabilities-
Total Equity-Paid-in Capital-
Representative (representative or managing partner)-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Largest Investor)-Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)-

c. Collective investment manager

(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))

(1) Collective investment manager overview

No.NameBusiness Registration No., etc.Target collective investment vehicleNationalityAddress (Location)Remarks
-------

(2) Collective investment manager details

Legal form-
Paid-in Capital-Total Assets Under Management-
Representative-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Corporate Representative)-Largest Shareholder Stake-

3. Shares, etc. held and holding ratio

Report reference dateReporting personShares, etc.Share CertificatesTotal Issued Voting Shares (shares)
Name of HolderNumber of Specially Related PersonsNumber of Shares, etc. (shares)Ratio (%)Number of Shares (shares)Ratio (%)
Previous Report2026-10-28조용준810,604,67837.1810,546,67837.0528,464,992
This Report2026-11-06조용준810,611,42437.2010,553,42437.0828,464,992
Change6,7460.026,7460.030

▶ 주식등의 비율(%)은 주식등의 수(주)를 의결권 있는 발행주식 총수(28,464,992주)와 보유 잠재주식 수(58,000주)를 합한 총수(28,522,992주)로 나누어 산정함.

4. Purpose of holding

Impact on management control
보고자와 특별관계자는 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각 호에 대한 사항에 대하여 회사의 최대주주로서 회사에 영향력을 행사하고 있습니다. 회사의 업무 집행과 관련한 주요사항이 발생할 경우에는 주주 및 이해관계자들의 이익을 고려하여 관계 법령 등에서 허용하는 범위 및 방법에 따라 회사의 경영목적에 부합하는 의사결정을 할 예정입니다.※ 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각 호(아래 1~10호)1. 이사 및 감사의 선임·해임 또는 직무의 정지2. 이사회 등 회사의 기관과 관련된 정관의 변경3. 회사의 자본금의 변경4. 회사의 배당의 결정5. 회사의 합병, 분할 및 분할합병6. 주식의 포괄적 교환 및 이전7. 영업전부의 양수·양도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수·양도8. 자산의 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분9. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익전부를 같이 하는 계약, 그 밖에 이에 준하는 계약의 체결·변경 또는 해약10. 회사의 해산

5. Reason for change

Method of change장내 거래
Reason for change장내 거래에 따른 보유주식수 변동
Reason for Change-

Part 2 Details of Large Holdings

1. Holdings by reporting person and specially related persons

A. Holdings by type of shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Shares Held
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person조용준6606128,075,209--------8,075,20928.31
Specially Related Party이경옥3912101,780,660--------1,780,6606.24
김도형730123383,310--------383,3101.34
조은숙64062072,600--------72,6000.25
조은경69050754,960--------54,9600.19
조유진9801264,500--------4,5000.02
조호윤021107161,185--------161,1850.57
신중현610620--------35,00035,0000.12
장준일73052821,000-------23,00044,0000.15
Aa1a2BCDEFG
H

▶ 합계의 비율(%)은 합계 주수(주)를 제2부 1. (보고자 및 특별관계자별 보유내역) 상의 의결권 있는 발행주식 총수(28,464,992주)와 보유 잠재주식의 수(58,000주)를 합한 총수(28,522,992주)로 나누어 산정함.

Total Issued Voting Shares (I)Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H)Holding Ratio (%)
Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100Share Holding Ratio (A / I) × 100
28,464,99258,00037.2037.08

▶ 교환대상이 주식인 교환사채권, 기초자산이 주식인 증권예탁증권ㆍ파생결합증권 및 자기주식을 교부하는 주식매수선택권 등에 한하여 분모에서 제외하고 보유비율을 산정.▶ 주식 등의 보유비율 산정시 주식매수선택권 부여방법은 신주교부권, 자기주식교부, 차액 보상 중 행사시점에 회사에서 결정되나, 본 비율 산정시에는 신주교부를 가정하여 산출함.

B. Holdings by form of holding

RelationshipName (Entity Name)Date of Birth or Business Registration No., etc.Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act)Total
No. 1No. 2No. 3No. 4No. 5No. 6No. 7Number of sharesRatio
Reporting person조용준6606128,075,209------8,075,20928.31
Specially Related Party이경옥3912101,780,660------1,780,6606.24
김도형730123383,310------383,3101.34
조은숙64062072,600------72,6000.25
조은경69050754,960------54,9600.19
조유진9801264,500------4,5000.02
조호윤021107161,185------161,1850.57
신중현610620------35,00035,0000.12
장준일73052821,000-----23,00044,0000.15
※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them

2. Contracts on shares held

A. Contract status

Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.)
Yes

*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported

B. Contract details

No.Name (Entity Name)Relationship to ReporterDate of Birth or Business Registration No., etc.Type of shares, etc.Number of shares, etc.CounterpartyContract typeContract date (amendment date)Contract periodRatioRemarks
1-1이경옥Related party391210Voting Shares1,536,660한국증권금융담보계약2021-09-09담보해지시까지5.39질권설정
1-2이경옥Related party391210Voting Shares244,000한국증권금융담보계약2024-06-03담보해지시까지0.86질권설정
2-1조용준Self660612Voting Shares674,690NH Investment & Securities담보계약2021-07-13담보해지시까지2.37질권설정
2-2조용준Self660612Voting Shares952,000한국증권금융담보계약2021-09-09담보해지시까지3.33질권설정
2-3조용준Self660612Voting Shares240,000한국증권금융담보계약2024-06-03담보해지시까지0.84질권설정
2-4조용준Self660612Voting Shares1,100,000한국증권금융담보계약2026-03-27담보해지시까지3.86질권설정
2-5조용준Self660612Voting Shares771,970하나증권담보계약2023-12-21담보해지시까지2.71질권설정
2-6조용준Self660612Voting Shares919,628Korea Investment & Securities담보계약2023-12-21담보해지시까지3.22질권설정
2-7조용준Self660612Voting Shares1,108,191Shinhan Securities담보계약2025-06-11담보해지시까지3.88질권설정
Total (number of shares, etc.)7,547,139Total (ratio)26.46-

C. Additional details if the main contract is a security agreement

No.Number of shares, etc.Loan amountDebtorInterest rateCollateral maintenance ratioOther
1-11,536,6603,595,000,000이경옥4.95110-
1-2244,000144,000,000이경옥4.95110-
2-1674,6901,706,000,000조용준5.90200-
2-2952,0002,350,000,000조용준4.95110-
2-3240,00013,000,000조용준4.95110-
2-41,100,0002,450,000,000조용준5.70110-
2-5771,9704,193,500,000조용준6.00160-
2-6919,6283,000,000,000조용준6.00170-
2-71,108,1912,260,709,800조용준5.90170-

3. Holdings by proprietary and customer account (financial institutions only)

NameRelationship to ReporterBy accountTotal
Own Account (shares)Ratio (%)Customer account (shares)Ratio (%)Total (shares)Ratio (%)
--------
Total------

Part 3 Material Changes Since Last Report Date

1. Summary of changes

a. Changes in shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Changes in Shares, etc.
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person조용준6606126,746--------6,7460.02
Specially Related Party이경옥391210-----------
김도형730123-----------
조은숙640620-----------
조은경690507-----------
조유진980126-----------
조호윤021107-----------
신중현610620-----------
장준일730528-----------

▶ 합계의 비율(%)은 합계 주수(주)를 제2부 1. (보고자 및 특별관계자별 보유내역) 상의 의결권 있는 발행주식 총수(28,464,992주)와 보유 잠재주식의 수(58,000주)를 합한 총수(28,522,992주)로 나누어 산정함

2. Change details

a. Detailed changes in shares, etc.

(Unit: shares, KRW)
Name (Entity Name)Date of Birth or Business Registration No., etc.Change Date*Acquisition/disposal methodType of shares, etc.Change detailsAcquisition/disposal unit price**Remarks
Before ChangeChangeAfter Change
조용준6606122026-10-29On-Market Purchase (+)Voting Shares8,068,4635,0468,073,5093,146( - )-
조용준6606122026-11-04On-Market Purchase (+)Voting Shares8,073,5091,7008,075,2093,353( - )-

* For trades on the securities market, the contract date

** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities

3. Source of acquisition funds

(1) Overview of acquisition funds

(Unit: KRW)
NameDate of birth or business registration no., etc.Own funds (H)Borrowings (I)Other (J)Total (H+I+J)
조용준66061221,574,595--21,574,595

(2) Origin and source of acquisition funds

ㅇ If own funds

NameDate of birth or business registration no., etc.Source and Formation of Acquisition Funds
조용준660612Employment Income